Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03635632
Title C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

uveal melanoma

Advanced Solid Tumor

breast cancer

osteosarcoma

neuroblastoma

Therapies

C7R-GD2.CART cells

Cyclophosphamide + Fludarabine

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.